Health ❯ Healthcare ❯ Patient Care ❯ Chronic Conditions

Diabetes Management

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

The once‑daily tablet offers an alternative to injectable PCSK9 drugs, with price, insurer coverage and ongoing outcomes data set to determine how widely it is used.

3 ARTICLES

4w ago

Study: GLP‑1 Use Soared and Shifted Costs From Patients to Insurers and Taxpayers

3 ARTICLES

4mo ago

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

Diabetes Management

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

Study: GLP‑1 Use Soared and Shifted Costs From Patients to Insurers and Taxpayers

Anvisa Authorizes Multidose Mounjaro Pen for Brazil

Anvisa Approves Tzield, First Therapy to Delay Onset of Type 1 Diabetes

Bundestag Passes Law Expanding Nursing Powers and Cutting Red Tape

Italy Rolls Out Weekly Insulin Therapy Despite Regional Disparities

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial